Literature DB >> 30854771

Winning the RACE: Expanding pediatric cancer drug approvals.

David S Shulman1, Steven G DuBois1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30854771      PMCID： PMC6588494          DOI： 10.1002/pbc.27705

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  9 in total

1.  Chimeric antigen receptor T cells for sustained remissions in leukemia.

Authors:  Shannon L Maude; Noelle Frey; Pamela A Shaw; Richard Aplenc; David M Barrett; Nancy J Bunin; Anne Chew; Vanessa E Gonzalez; Zhaohui Zheng; Simon F Lacey; Yolanda D Mahnke; Jan J Melenhorst; Susan R Rheingold; Angela Shen; David T Teachey; Bruce L Levine; Carl H June; David L Porter; Stephan A Grupp
Journal:  N Engl J Med       Date:  2014-10-16       Impact factor: 91.245

2.  Cancer drugs approved for use in children: Impact of legislative initiatives and future opportunities.

Authors:  Amy Barone; Denise Casey; Amy E McKee; Gregory Reaman
Journal:  Pediatr Blood Cancer       Date:  2019-05-30       Impact factor: 3.167

3.  Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.

Authors:  Alexander Drilon; Theodore W Laetsch; Shivaani Kummar; Steven G DuBois; Ulrik N Lassen; George D Demetri; Michael Nathenson; Robert C Doebele; Anna F Farago; Alberto S Pappo; Brian Turpin; Afshin Dowlati; Marcia S Brose; Leo Mascarenhas; Noah Federman; Jordan Berlin; Wafik S El-Deiry; Christina Baik; John Deeken; Valentina Boni; Ramamoorthy Nagasubramanian; Matthew Taylor; Erin R Rudzinski; Funda Meric-Bernstam; Davendra P S Sohal; Patrick C Ma; Luis E Raez; Jaclyn F Hechtman; Ryma Benayed; Marc Ladanyi; Brian B Tuch; Kevin Ebata; Scott Cruickshank; Nora C Ku; Michael C Cox; Douglas S Hawkins; David S Hong; David M Hyman
Journal:  N Engl J Med       Date:  2018-02-22       Impact factor: 91.245

4.  Enrolling Adolescents in Disease/Target-Appropriate Adult Oncology Clinical Trials of Investigational Agents.

Authors:  Meredith K Chuk; Yeruk Mulugeta; Michelle Roth-Cline; Nitin Mehrotra; Gregory H Reaman
Journal:  Clin Cancer Res       Date:  2016-10-25       Impact factor: 12.531

5.  Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer.

Authors:  Gregory T Armstrong; Yan Chen; Yutaka Yasui; Wendy Leisenring; Todd M Gibson; Ann C Mertens; Marilyn Stovall; Kevin C Oeffinger; Smita Bhatia; Kevin R Krull; Paul C Nathan; Joseph P Neglia; Daniel M Green; Melissa M Hudson; Leslie L Robison
Journal:  N Engl J Med       Date:  2016-01-13       Impact factor: 91.245

6.  Modernizing Clinical Trial Eligibility: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Minimum Age Working Group.

Authors:  Lia Gore; S Percy Ivy; Frank M Balis; Eric Rubin; Katherine Thornton; Martha Donoghue; Samantha Roberts; Suanna Bruinooge; Jennifer Ersek; Nancy Goodman; Caroline Schenkel; Gregory Reaman
Journal:  J Clin Oncol       Date:  2017-10-02       Impact factor: 44.544

7.  Chronic health conditions in adult survivors of childhood cancer.

Authors:  Kevin C Oeffinger; Ann C Mertens; Charles A Sklar; Toana Kawashima; Melissa M Hudson; Anna T Meadows; Debra L Friedman; Neyssa Marina; Wendy Hobbie; Nina S Kadan-Lottick; Cindy L Schwartz; Wendy Leisenring; Leslie L Robison
Journal:  N Engl J Med       Date:  2006-10-12       Impact factor: 176.079

8.  Joint adolescent-adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform-ACCELERATE.

Authors:  N Gaspar; L V Marshall; D Binner; R Herold; R Rousseau; P Blanc; R Capdeville; J Carleer; C Copland; Y Kerloeguen; K Norga; L Pacaud; M-A Sevaux; C Spadoni; J Sterba; F Ligas; T Taube; M Uttenreuther-Fischer; S Chioato; M A O'Connell; B Geoerger; J-Y Blay; J C Soria; S Kaye; B Wulff; L Brugières; G Vassal; A D J Pearson
Journal:  Ann Oncol       Date:  2018-03-01       Impact factor: 32.976

9.  Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival.

Authors:  Ahmedin Jemal; Elizabeth M Ward; Christopher J Johnson; Kathleen A Cronin; Jiemin Ma; Blythe Ryerson; Angela Mariotto; Andrew J Lake; Reda Wilson; Recinda L Sherman; Robert N Anderson; S Jane Henley; Betsy A Kohler; Lynne Penberthy; Eric J Feuer; Hannah K Weir
Journal:  J Natl Cancer Inst       Date:  2017-09-01       Impact factor: 13.506
  9 in total
  4 in total

1.  Ethical Challenges in Pediatric Oncology Care and Clinical Trials.

Authors:  Daniel J Benedetti; Jonathan M Marron
Journal:  Recent Results Cancer Res       Date:  2021

2.  Landscape of phase 1 clinical trials for minors with cancer in the United States.

Authors:  Jaclynne H Nader; Dylan V Neel; David S Shulman; Clement Ma; Florence Bourgeois; Steven G DuBois
Journal:  Pediatr Blood Cancer       Date:  2020-09-04       Impact factor: 3.167

3.  Sponsorship of oncology clinical trials in the United States according to age of eligibility.

Authors:  Dylan V Neel; David S Shulman; Clement Ma; Florence Bourgeois; Steven G DuBois
Journal:  Cancer Med       Date:  2020-04-29       Impact factor: 4.452

4.  Off-label prescribing of targeted anticancer therapy at a large pediatric cancer center.

Authors:  Mir Lim; David S Shulman; Holly Roberts; Anran Li; Jessica Clymer; Kira Bona; Hasan Al-Sayegh; Clement Ma; Steven G DuBois
Journal:  Cancer Med       Date:  2020-08-04       Impact factor: 4.711
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.